학술논문

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study
Document Type
article
Source
Gynecologic Oncology. 156(1)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Ovarian Cancer
Depression
Behavioral and Social Science
Prevention
Rare Diseases
Clinical Research
Clinical Trials and Supportive Activities
Mental Health
Cancer
Patient Safety
Adult
Aged
Cohort Studies
Early Detection of Cancer
Female
Follow-Up Studies
Humans
Middle Aged
Ovarian Neoplasms
Prospective Studies
Quality of Life
Salpingo-oophorectomy
Paediatrics and Reproductive Medicine
Oncology & Carcinogenesis
Clinical sciences
Oncology and carcinogenesis
Reproductive medicine
Language
Abstract
BackgroundRisk-reducing salpingo-oophorectomy (RRSO) and ovarian cancer screening (OCS) are management options for women at increased risk of ovarian cancer. Long-term effects of these interventions on quality of life (QOL) are not well understood.MethodsGOG-0199 is a prospective cohort study of women at increased ovarian cancer risk who chose either RRSO or OCS as their risk management intervention. At study entry, 6, 12, 24 and 60 months of follow-up, participants completed the QOL questionnaire, which included the Medical Outcome Study Short Form-36, the Impact of Events Scales, the Center for Epidemiological Studies Depression Scale, the State-Trait Anxiety Inventory, the Functional Assessment of Cancer Therapy - Endocrine Subscale, and the Sexual Activity Questionnaire. QOL measures were compared between the RRSO and OCS cohort at baseline and over time.ResultsFive-hundred-sixty-two participants in the RRSO cohort and 1,010 in the OCS completed the baseline and at least one follow-up questionnaire. At baseline, participants selecting RRSO reported lower health-related QOL (HRQOL), greater ovarian cancer-related stress, greater anxiety, and more depressive symptomatology, which improved during follow-up, especially for ovarian cancer-related stress. Screening was not found to adversely impact HRQOL. Hormone-related menopausal symptoms worsened and sexual functioning declined during follow-up in both cohorts, but more so among participants who underwent RRSO.ConclusionsHRQOL improved after surgery among women who chose RRSO and remained stable among participants undergoing screening. The adverse effects of RRSO and screening on short-term and long-term sexual activity and sexual functioning warrant consideration in the decision-making process for high-risk women.